Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors

By          

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 208-214

Spandidos Publications

Access to resources Recommend Favorite

Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer

By Krahn G.   Leiter U.   Kaskel P.   Udart M.   Utikal J.   Bezold G.   Peter R.U.  

European Journal of Cancer, Vol. 37, Iss. 2, 2001-01 ,pp. : 251-259

Elsevier

Access to resources Recommend Favorite

Concordance of HER2 in primary tumor and leptomeningeal metastases: now what?

By Lin Nancy  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 129-131

Springer Publishing Company

Access to resources Recommend Favorite

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

By Lipton Allan   Goodman Laurie   Leitzel Kim   Cook Jennifer   Sperinde Jeff   Haddad Mojgan   Köstler Wolfgang   Huang Weidong   Weidler Jodi   Ali Suhail   Newton Alicia   Fuchs Eva-Marie   Paquet Agnes   Singer Christian   Horvat Reinhard   Jin Xueguang   Banerjee Joyee   Mukherjee Ali   Tan Yuping   Shi Yining   Chenna Ahmed   Larson Jeff   Lie Yolanda   Sherwood Thomas   Petropoulos Christos   Williams Stephen   Winslow John   Parry Gordon   Bates Michael  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 43-53

Springer Publishing Company

Access to resources Recommend Favorite

Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer

By Ferrandina G.   Ranelletti F.O.   Lauriola L.   Fanfani F.   Legge F.   Mottolese M.   Nicotra M.R.   Natali P.G.   Zakut V.H.   Scambia G.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 305-310

Academic Press

Access to resources Recommend Favorite